NZ Breast Cancer Research Review Issue 26

In this issue:

TILs and prognosis in early-stage TNBC
Trastuzumab emtansine for residual HER2+ disease
Atezolizumab + nabpaclitaxel in advanced TNBC
T-DM1 safe in previously treated HER2+ advanced disease
Long-term follow-up of the BIG 1-98 trial
Microductectomy: necessary to diagnose breast cancer?
Outcomes of immediate implant-based breast reconstruction
Recent childbirth a risk factor for breast cancer
Estimating upgrade rates in excised radial scar subgroups
Early surveillance for lymphoedema

Please login below to download this issue (PDF)